Probably most of us who’ve had treatment for our myeloma have been prescribed one of the drugs manufactured by Celgene. Celgene makes Revlimid® (lenalidomide) and Thalomid® (thalidomide).
That really annoying guy on TV, Jim Cramer (Mad Money, CNBC), says it’s on his list of stuff to buy. According to the CNBC site:
So when do you buy CELG? Cramer said that investors could wait until the annual American Society of Hematology (ASH) meeting on Dec. 5, where Celgene is expected to present “some terrific Revlimid data.”
“I wouldn’t pull the trigger on this trade until the week before the conference,” Cramer said.
I’ll be waiting to see what happens during the ASH conference.